GlassScriptPhysician profile
Anish Koka
NPI 1740236124
$29,268.91
in general payments reported to CMS, 2019-2025
44 companies · $2,006 in 2025
The $2,006 reported for 2025 was more than what 83% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,439 · 2020: $7,741 · 2021: $3,964 · 2022: $1,629 · 2023: $3,190 · 2024: $1,300 · 2025: $2,006.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,383 · Travel and Lodging: $1,112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,383.26 |
| Travel and Lodging | $1,112.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $12,915.51 | 2019-2024 | Farxiga, Wainua, Lokelma |
| Boehringer Ingelheim Pharmaceuticals, INC. | $3,412.59 | 2019-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $2,730.96 | 2019-2024 | Xarelto |
| Amgen INC. | $2,290.34 | 2019-2025 | Repatha, Repatha |
| Medtronic, INC. | $1,631.78 | 2022-2023 | Venaseal, Cobalt Dr Mri Surescan |
| Novo Nordisk INC | $1,207.11 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Pfizer INC. | $1,137.69 | 2019-2025 | |
| Actelion Pharmaceuticals US, INC. | $446.69 | 2020-2025 | Opsumit, Uptravi |
| Heartflow, INC. | $424.13 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $369.63 | 2021-2024 | Verquvo |
| E.R. Squibb & Sons, L.L.C. | $331.49 | 2020-2025 | Camzyos, Eliquis |
| Boston Scientific Corporation | $235.50 | 2019-2025 | General - Therapies, Watchman Flx |
| Abbott Laboratories | $225.67 | 2021-2025 | Freestyle Libre 3, Jot Dx |
| Alnylam Pharmaceuticals INC. | $198.52 | 2024-2025 | Onpattro, Amvuttra |
| Onkos Surgical, INC. | $183.17 | 2021 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anish Koka listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.